Drug companies directed to step up vigil on adverse reactions

India's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes amid global scrutiny of India's drug safety monitoring. Companies must now designate officers, maintain records, and report reactions promptly. Compliance will be checked during routine inspections. This ensures better post-market drug safety for consumers.